There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks
These medications work by mimicking the actions of the glucagon-like peptide-1 hormone, aiding in blood sugar regulation and promoting a feeling of fullness
Lets take a deeper look into these challenges, their impact, and how employers can take a more strategic approach to offering weight loss programs for their people
Cell 187:63466357.e20 Gasaly N, Hermoso MA, Gotteland M (2021) Butyrate and the fine-tuning of colonic homeostasis: implication for inflammatory bowel diseases
Administration and Guidance CJC-1295 is administered via subcutaneous injection, typically in the evening to align with natural GH release patterns during sleep